Search Results 401-410 of 57137 for Compliance

1. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

   ... compliance with the protocol or interpretation of results. -Evidence of any significant, uncontrolled concomitant disease that could affect compliance ...

2. Development of a Patient-Centered Quality of Life Outcome Measure Following Parotidectomy - Mayo Clinic

   Participants not residing in the United States (to avoid potential EU GDPR compliance issues). Note: Other protocol defined Inclusion/Exclusion Criteria may ...

3. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Chronic Pain Patients to Assess Current and Future Therapeutic Relevance

   ... compliance with the study requirements or the ability to willingly give written informed consent. Participating Mayo Clinic locations. Study statuses change ...

4. David J. DiSantis, M.D. - Doctors and Medical Staff - Mayo Clinic

   ChairQuality, Safety & Compliance, University of Kentucky Medical Center. 2011 - 2012. Medical DirectorQuality, Safety & Compliance, University of Kentucky ...

5. Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer - Mayo Clinic

   ... compliance with study requirements. Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm. Other ...

6. Evaluating the Impact of InSee on Incentive Spirometer Utilization - Mayo Clinic

   Patients with a history of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction), delirium, or ...

7. Growth Hormone for the Treatment of Gastroparesis - Mayo Clinic

   Any other condition, which in the opinion of the investigator would impede compliance or hinder completion of the study. Failure to give informed consent ...

8. OTL38 for Intraoperative Imaging of Folate Receptor Positive Lung Nodules - Mayo Clinic

   Presence of any psychological, familial, sociological condition or geographical challenges potentially hampering compliance with the study protocol and follow- ...

9. Tradipitant After GLP-1R Agonist In Healthy, Overweight, or Class I or II Obese Volunteers - Mayo Clinic

   ... compliance with study procedures;; Current clinically significant cardiovascular, respiratory, neurologic, hepatic, hematopoietic, renal, gastrointestinal or ...

10. Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation - Mayo Clinic

    demonstrated lack of compliance; averaged more than 4 spontaneous bowel movements per week; Substudy patients only: did not demonstrate slow colonic transit ...